Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two lipid emulsions in total parenteral nutrition for critically ill ICU patients
2004-001299-38Phase 4Active
- Sponsor
- Metabolism and Nutrition Working Group of SEMICYUC
- Start
- Dec 2004
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of medium-chain triglycerides + soybean oil and long-chain triglyceride lipid emulsion in Critical illness with parenteral nutrition requirement and Healthcare-associated infection (HAI) (2 arms), sponsored by Metabolism and Nutrition Working Group of SEMICYUC. Primary endpoint: Incidence density of nosocomial infections. Started Dec 2004; status: active.
02
Drugs
medium-chain triglycerides + soybean oillong-chain triglyceride lipid emulsion
03
Conditions
Critical illness with parenteral nutrition requirementHealthcare-associated infection (HAI)
Beyond the preview
Go deeper on 2004-001299-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001299-38.